| | |

Pediatric rheumatologists,researchers and families, working hand in hand to support groundbreaking,
life-changing research and treatment for children living with arthritis and lupus.

New Lupus Treatment Being Tested for Younger Patients

Delazatide may be effective to control flares in lupus nephritis patients, according to recent data from The Alliance for Children’s Therapeutics (ACT), a pediatric research collaboration between Seattle Children’s Research Institute and the biotech company Kineta, Inc. The results were presented during the recent American College of Rheumatology Annual Meeting in San Francisco, California. Read More... | Finland | Helsinki | Denmark